-
1 Comment
Shanghai No.1 Pharmacy Co., Ltd is currently in a long term downtrend where the price is trading 9.2% below its 200 day moving average.
From a valuation standpoint, the stock is 85.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
Shanghai No.1 Pharmacy Co., Ltd's total revenue rose by 21.1% to $392M since the same quarter in the previous year.
Its net income has dropped by 27.1% to $11M since the same quarter in the previous year.
Finally, its free cash flow grew by 22.6% to $37M since the same quarter in the previous year.
Based on the above factors, Shanghai No.1 Pharmacy Co., Ltd gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Pharmaceutical Retailers |
| Exchange | SHG |
| CurrencyCode | CNY |
| ISIN | CNE000000412 |
| Target Price | None |
|---|---|
| Beta | 0.56 |
| PE Ratio | 16.78 |
| Market Cap | 3B |
| Dividend Yield | None |
Shanghai No.1 Pharmacy Co.,Ltd., together with its subsidiaries, engages in the retail and wholesale of pharmaceutical products in China. The company also sells food, medical equipment, health convenience products, and other commodities. It serves terminal medicinal institutions and pharmaceutical companies. Shanghai No. 1 Pharmacy Co.,Ltd. was founded in 1992 and is headquartered in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600833.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
